Literature DB >> 21196052

Depressive symptoms evaluated by the Calgary Depression Scale for Schizophrenia (CDSS): genetic vulnerability and sex effects.

Migdyrai Martín-Reyes1, Raúl Mendoza, Mayelín Domínguez, Antonio Caballero, Tania Marta Bravo, Thais Díaz, Seidel Gerra, Agustín Ibáñez, Andres Ruiz Linares.   

Abstract

The present study compares the occurrence of depressive symptoms evaluated by the Calgary Depression Scale for Schizophrenia (CDSS) in patients of Multiplex (MS) and Simplex Schizophrenia families (SS). The Positive and Negative Syndrome Scale (PANSS) was used to evaluate psychopathology. A total of 206 paranoid schizophrenia patients were studied according DSM-IV criteria. The Family Interview for Genetic Studies (FIGS) was used to study the families. A result in the FIGS for a positive family history of schizophrenia was referred as MS (patients); its lack as SS (patients). CDSS scores were compared among MS and SS patients and possible sex differences intra- and inter-groups were explored. In the analysis of our sample (30) 19% of the total persons with schizophrenia group was depressed. The depressive symptoms measured by the CDSS were higher in females and the MS males group. Males from MS group showed more depressive symptoms than males from SS group. No differences with females from both groups were found. Findings in this study underscore the importance of gender and family history in understanding the heterogeneity of schizophrenia. This study suggests that sex and familiar history are important to consider in studying depressive symptoms.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21196052     DOI: 10.1016/j.psychres.2010.11.026

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  5 in total

1.  Does age moderate the relationship between depressive symptoms and suicidal ideation in middle-aged and older patients with schizophrenia and subthreshold depression?

Authors:  John Kasckow; Shahrokh Golshan; Sidney Zisook
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

2.  Structural abnormalities of cingulate cortex in patients with first-episode drug-naïve schizophrenia comorbid with depressive symptoms.

Authors:  Gao-Xia Wei; Likun Ge; Li-Zhen Chen; Bo Cao; Xiangyang Zhang
Journal:  Hum Brain Mapp       Date:  2020-12-09       Impact factor: 5.038

3.  Gender Differences of Schizophrenia Patients With and Without Depressive Symptoms in Clinical Characteristics.

Authors:  Ruimei Liu; Xinyu Fang; Lingfang Yu; Dandan Wang; Zenan Wu; Chaoyue Guo; Xinyue Teng; Juanjuan Ren; Chen Zhang
Journal:  Front Psychiatry       Date:  2022-01-13       Impact factor: 4.157

4.  Depressive symptoms in first episode psychosis: a one-year follow-up study.

Authors:  Nasrettin Sönmez; Kristin Lie Romm; Ole A Andreasssen; Ingrid Melle; Jan Ivar Røssberg
Journal:  BMC Psychiatry       Date:  2013-04-05       Impact factor: 3.630

5.  Depressive Symptoms during an Acute Schizophrenic Episode: Frequency and Clinical Correlates.

Authors:  Ravi Philip Rajkumar
Journal:  Depress Res Treat       Date:  2015-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.